Cargando…

Role of platelet chemokines, PF-4 and CTAP-III, in cancer biology

With the recent addition of anti-angiogenic agents to cancer treatment, the angiogenesis regulators in platelets are gaining importance. Platelet factor 4 (PF-4/CXCL4) and Connective tissue activating peptide III (CTAP-III) are two platelet-associated chemokines that modulate tumor angiogenesis, inf...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pilatova, Katerina, Greplova, Kristina, Demlova, Regina, Bencsikova, Beatrix, Klement, Giannoula Lakka, Zdrazilova-Dubska, Lenka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3694472/ https://www.ncbi.nlm.nih.gov/pubmed/23800319 http://dx.doi.org/10.1186/1756-8722-6-42

Ejemplares similares

Circulating T cell subsets are associated with clinical outcome of anti-VEGF-based 1st-line treatment of metastatic colorectal cancer patients: a prospective study with focus on primary tumor sidedness
por: Bencsikova, Beatrix, et al.
Publicado: (2019)

Editorial: Precision/Personalized Pediatric Oncology and Immune Therapies: Rather Customize Than Randomize
por: Kýr, Michal, et al.
Publicado: (2020)

B-Cell Activating Factor as a Cancer Biomarker and Its Implications in Cancer-Related Cachexia
por: Rihacek, Michal, et al.
Publicado: (2015)

Platelet Proteome and Tumor Dormancy: Can Platelets Content Serve as Predictive Biomarkers for Exit of Tumors from Dormancy?
por: Almog, Nava, et al.
Publicado: (2010)

Assessment of Immune Response Following Dendritic Cell-Based Immunotherapy in Pediatric Patients With Relapsing Sarcoma
por: Fedorova, Lenka, et al.
Publicado: (2019)

Dendritic Cell-Based Immunotherapy in Advanced Sarcoma and Neuroblastoma Pediatric Patients: Anti-cancer Treatment Preceding Monocyte Harvest Impairs the Immunostimulatory and Antigen-Presenting Behavior of DCs and Manufacturing Process Outcome
por: Hlavackova, Eva, et al.
Publicado: (2019)

Efficacy of bevacizumab and chemotherapy in the first-line treatment of metastatic colorectal cancer: broadening KRAS-focused clinical view
por: Bencsikova, Beatrix, et al.
Publicado: (2015)

Minimal Residual Disease–Guided Intermittent Dosing in Patients With Cancer: Successful Treatment of Chemoresistant Anaplastic Large Cell Lymphoma Using Intermittent Lorlatinib Dosing
por: Pokorna, Petra, et al.
Publicado: (2022)

Colorectal Tumour Mucosa Microbiome Is Enriched in Oral Pathogens and Defines Three Subtypes That Correlate with Markers of Tumour Progression
por: Zwinsová, Barbora, et al.
Publicado: (2021)

Adjustment of serum HE4 to reduced glomerular filtration and its use in biomarker-based prediction of deep myometrial invasion in endometrial cancer
por: Chovanec, Josef, et al.
Publicado: (2017)

1563MO CoVigi phase IV multicentric trial evaluating COVID-19 vaccination adverse events and immune response dynamics in cancer patients: First results on antibody and cellular immunity
por: Obermannova, R., et al.
Publicado: (2021)

Bangladesh Chars Tobacco Assessment Project (CTAP) 2018: a data note
por: Fakir, Adnan M. S., et al.
Publicado: (2018)

Molecular portraits of colorectal cancer morphological regions
por: Budinská, Eva, et al.
Publicado: (2023)

PET/CT-tailored treatment of locally advanced oesophago-gastric junction adenocarcinoma: a report on the feasibility of the multicenter GastroPET study
por: Obermannova, Radka, et al.
Publicado: (2022)

Design principles for cancer therapy guided by changes in complexity of protein-protein interaction networks
por: Benzekry, Sebastian, et al.
Publicado: (2015)

Gibbs Energy and Gene Expression Combined as a New Technique for Selecting Drug Targets for Inhibiting Specific Protein–Protein Interactions
por: Rietman, Edward A., et al.
Publicado: (2023)

Normal Wound Healing and Tumor Angiogenesis as a Game of Competitive Inhibition
por: Kareva, Irina, et al.
Publicado: (2016)

Personalized anticancer therapy selection using molecular landscape topology and thermodynamics
por: Rietman, Edward A., et al.
Publicado: (2016)

Hidden threat of tortoise ticks: high prevalence of Crimean-Congo haemorrhagic fever virus in ticks Hyalomma aegyptium in the Middle East
por: Široký, Pavel, et al.
Publicado: (2014)

Characterisation of small molecule ligands 4CMTB and 2CTAP as modulators of human FFA2 receptor signalling
por: Schofield, Zoe V., et al.
Publicado: (2018)

Comprehensive Molecular Profiling for Relapsed/Refractory Pediatric Burkitt Lymphomas—Retrospective Analysis of Three Real-Life Clinical Cases—Addressing Issues on Randomization and Customization at the Bedside
por: Polaskova, Kristyna, et al.
Publicado: (2020)

Personalized therapy design for systemic lupus erythematosus based on the analysis of protein-protein interaction networks
por: Brant, Elizabeth J., et al.
Publicado: (2020)

Two Permeases Associated with the Multifunctional CtaP Cysteine Transport System in Listeria monocytogenes Play Distinct Roles in Pathogenesis
por: Vaval Taylor, Diandra M., et al.
Publicado: (2023)

Study of the Binding Pattern of HLA Class I Alleles of Indian Frequency and cTAP Binding Peptide for Chikungunya Vaccine Development
por: Saxena, Prashant, et al.
Publicado: (2020)

Predicting the targets of IRF8 and NFATc1 during osteoclast differentiation using the machine learning method framework cTAP
por: Wang, Honglin, et al.
Publicado: (2022)

Chikungunya Virus Vaccine Development: Through Computational Proteome Exploration for Finding of HLA and cTAP Binding Novel Epitopes as Vaccine Candidates
por: Sharma, Priti, et al.
Publicado: (2022)

Dynamics of CXC group chemokine platelet factor 4 (PF4) plasma levels in non-small cell lung cancer (NSCLC)
por: Spaks, Artjoms, et al.
Publicado: (2012)

Platelets and their chemokines in atherosclerosis—clinical applications
por: von Hundelshausen, Philipp, et al.
Publicado: (2014)

Different Activity of the Biological Axis VEGF-Flt-1 (fms-Like Tyrosine Kinase 1) and CXC Chemokines between Pulmonary Sarcoidosis and Idiopathic Pulmonary Fibrosis: A Bronchoalveolar Lavage Study
por: Antoniou, Katerina M., et al.
Publicado: (2009)

Individualization of Treatment Improves the Survival of Children With High-Risk Solid Tumors: Comparative Patient Series Analysis in a Real-Life Scenario
por: Kyr, Michal, et al.
Publicado: (2019)

Plasmodium falciparum PfEMP1 Modulates Monocyte/Macrophage Transcription Factor Activation and Cytokine and Chemokine Responses
por: Sampaio, Natália Guimarães, et al.
Publicado: (2017)

Platelet-Derived Microparticles Bearing PF4 and Anti-GAGS Immunoglobulins in Patients with Sepsis
por: Sartori, Maria Teresa, et al.
Publicado: (2020)

Effect of PF-04634817, an Oral CCR2/5 Chemokine Receptor Antagonist, on Albuminuria in Adults with Overt Diabetic Nephropathy
por: Gale, Jeremy D., et al.
Publicado: (2018)

The Book of PF
por: Hansteen, Peter
Publicado: (2014)

2508: The role of platelet factor-4 (PF4 or CXCL4) in B cell differentiation
por: Blick, Sara, et al.
Publicado: (2018)

Synthesis and Biological Evaluation of BODIPY-PF-543
por: Shrestha, Jitendra, et al.
Publicado: (2019)

Misclassification of PfEH1 and PfEH2 as Epoxide Hydrolases
por: Arand, Michael, et al.
Publicado: (2017)

Richer concepts are better remembered: number of features effects in free recall
por: Hargreaves, Ian S., et al.
Publicado: (2012)

COVID-19 adenovirus vaccine triggers antibodies against PF4 complexes to activate complement and platelets
por: Pitkänen, Hanna H., et al.
Publicado: (2021)

Platelet-activating anti-PF4 antibodies mimic VITT antibodies in an unvaccinated patient with monoclonal gammopathy
por: Greinacher, Andreas, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4jas48od44hl4q5du3hma2tphb